APRI (Aspartate Aminotransferase to Platelet Ratio Index)
APRI is a biomarker used to assess liver fibrosis by calculating the ratio of aspartate aminotransferase (AST) to platelet count.
APRI measures liver fibrosis using AST and platelet ratio.
Key facts at a glance
- Units
- ratio
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- FibroMeter APRI, APRI Calculator
APRI is calculated using the formula: (AST level / upper limit of normal AST) / platelet count (109/L) x 100. It is a non-invasive method to evaluate liver fibrosis, particularly in patients with chronic hepatitis C.
A higher APRI score indicates a greater likelihood of significant liver fibrosis or cirrhosis. The test is particularly useful in resource-limited settings where other diagnostic tools may not be readily available.
While APRI is a valuable screening tool, it is not definitive. Other tests and clinical assessments are often needed to confirm the diagnosis and severity of liver disease.
Frequently asked questions
What is a normal APRI score?
Can APRI diagnose liver disease on its own?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy